Concepedia

Brandon Drennen

BD

Statistics

Publications

5

Citations

113

H-Index

5

Active since

2015

Affiliations

University of Maryland, Baltimore(Current)

U-M Rogel Cancer Center

University of Baltimore

Cardiff University

Brandon Drennen is an author at University of Maryland, Baltimore specializing in pharmacology, medicinal chemistry, and drug discovery.

Publications per year

2015–2022

5

Publications

5

Structure-based design of 3-carboxy-substituted 1,2,3,4-tetrahydroquinolines as inhibitors of myeloid cell leukemia-1 (Mcl-1)

Lingtao Chen, Paul T. Wilder, Brandon Drennen et al. · Organic & Biomolecular Chemistry · 2015 · 39 citations

, , +14

Structural Re‐engineering of the α‐Helix Mimetic JY‐1‐106 into Small Molecules: Disruption of the Mcl‐1–Bak‐BH3 Protein–Protein Interaction with 2,6‐Di‐Substituted Nicotinates

Brandon Drennen, Jacob A. Scheenstra, Jeremy L. Yap et al. · ChemMedChem · 2016 · 28 citations · Full text

, , +16

Towards more drug-like proteomimetics: two-faced, synthetic α-helix mimetics based on a purine scaffold

Maryanna E. Lanning, Paul T. Wilder, Hala Bailey et al. · Organic & Biomolecular Chemistry · 2015 · 16 citations · Full text

, , +8

Scaffold hopping from indoles to indazoles yields dual MCL-1/BCL-2 inhibitors from MCL-1 selective leads

Brandon Drennen, Christopher C. Goodis, Nathan G. Bowen et al. · RSC Medicinal Chemistry · 2022 · 16 citations · Full text

, , +15

Rationally Designed Polypharmacology: α‐Helix Mimetics as Dual Inhibitors of the Oncoproteins Mcl‐1 and HDM2

Ivie L. Conlon, Brandon Drennen, Maryanna E. Lanning et al. · ChemMedChem · 2020 · 14 citations · Full text

, , +17

1–5 of 5